Physician

Zane A Darnell, MD

According to 2025 Medicare claims, Zane Darnell, MD (NPI: 1356330732) practices cardiology in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Greenup, KY. This provider's primary affiliated billing organization is KINGS DAUGHTERS MEDICAL SPECIALTIES INC. (NPI: 1134484892; TIN: 264183569) and primary practice location at 41101-2843.

Darnell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,376 traditional Medicare patients, billed 6,587 HCPCS/CPT codes, and received $278,112 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 8,134 prescription claims across 1,508 beneficiaries totaling $1,325,524 in drug costs, led by Entresto (Sacubitril/Valsartan). 2023 DME data shows 23 claims. Open Payments data shows 9 records totaling $165. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $463,821 to $278,112. In contrast, Part D prescription costs have moved sharply higher in recent years, from $529,022 to $1,325,524. For DME billing, this smaller-volume category did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	3,215	8,135	$463,821
2016	3,654	8,839	$468,304
2017	5,550	12,172	$425,677
2018	5,720	13,210	$442,557
2019	5,367	12,693	$472,379
2020	4,862	11,430	$407,185
2021	4,295	9,602	$372,189
2022	4,409	10,438	$378,927
2023	3,306	8,252	$318,642
2024	2,376	6,587	$278,112

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,412	12,136	$529,022
2016	1,375	8,986	$422,124
2017	1,247	8,785	$431,243
2018	1,277	7,398	$408,914
2019	1,287	6,991	$499,199
2020	1,270	6,477	$515,289
2021	1,297	6,518	$534,545
2022	1,267	5,785	$581,008
2023	1,387	6,693	$965,414
2024	1,508	8,134	$1,325,524

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	69	$4,349
2016	N/R	60	$3,385
2017	N/R	67	$25,122
2018	11	41	$56,743
2019	19	51	$110,529
2020	20	65	$137,293
2021	21	69	$145,400
2022	11	40	$85,569
2023	11	23	$57,763
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	886	1,379	$63
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	294	294	$53
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	604	616	$48
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	343	379	$45
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,461	1,931	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	360	19,680	$434,518
Eliquis	Apixaban	245	14,173	$270,598
Jardiance	Empagliflozin	232	13,888	$269,903
Farxiga	Dapagliflozin Propanediol	141	8,203	$150,228
Xarelto	Rivaroxaban	49	3,570	$64,359

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$165	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Zane A. Darnell, MD?

Tedicare shows public-source Medicare data for Zane A. Darnell, MD (NPI 1356330732), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Zane A. Darnell, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Zane A. Darnell, MD?

Zane A. Darnell, MD is linked to KINGS DAUGHTERS MEDICAL SPECIALTIES INC. (billing NPI 1134484892) in the available physician profile data.

Does Zane A. Darnell, MD have Open Payments data?

Zane A. Darnell, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.